Collection of ECG data in COVID-19 clinical trials

This document provides guidance for a general process for collecting the standard 12-lead clinical trial ECG data, to support any trial-specific instructions. It does not include ambulatory (e.g. Holter) ECGs. The document, which is not prescriptive, may be adapted by sites as required.

This guidance document has been adapted from the WWARN Clinical Trials Toolkit for COVID-19 clinical trials. Authors: WWARN, Banook Group & LSTM